BHVNBiohaven Ltd.

$1B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$219M

Net Income

-$214M

EPS (Diluted)

$-5.97

Cash Flow

Operating Cash Flow

-$146M

Free Cash Flow

-$147M

Stock-Based Comp.

$66M

Balance Sheet

Total Assets

$142M

Total Liabilities

$47M

Stockholders' Equity

$35M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$219M	-$115M	-91.2%
Net Income	-$214M	-$119M	-80.2%

BHVN FY 2021 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena